News As Streeting threatens no deal, talks on drug levy collapse The UK government's threat to withdraw from negotiations on rebates paid by industry on NHS medicines has been followed by the collapse of talks.
News Ionis brings long-acting treatment option to HAE patients Ionis gets FDA nod for its HAE attack prophylactic treatment Dawnzera, offering less frequent dosing than its rivals.
News EU-US trade deal includes 15% pharma tariff Details have been published of the trade agreement between the US and EU, with confirmation of the tariff rates for pharmaceuticals.
News J&J earmarks $2bn for facility in North Carolina Johnson & Johnson has filled in some of the detail in its $55 billion investment in US facilities announced earlier this year.
News NICE backs bladder cancer duo that can double survival A new treatment regimen for advanced bladder cancer combining MSD's Keytruda with Astellas' Padcev has been given the green light for NHS use.
News PTC stung by FDA decision not to approve rare disease drug It looks like PTC will have to carry out another trial of its drug for Friedreich ataxia before the FDA will consider approval.
News Pharvaris plans filings for HAE drug after pivotal trial win Pharvaris has reported positive data from a phase 3 trial of its drug for preventing HAE attacks, setting up marketing applications next year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.